Global Brain Cancer Diagnostics Supply, Demand and Key Producers, 2024-2030

Description

The global Brain Cancer Diagnostics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Brain Cancer Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Brain Cancer Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Brain Cancer Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Brain Cancer Diagnostics total market, 2019-2030, (USD Million)
Global Brain Cancer Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Brain Cancer Diagnostics total market, key domestic companies and share, (USD Million)
Global Brain Cancer Diagnostics revenue by player and market share 2019-2024, (USD Million)
Global Brain Cancer Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)
Global Brain Cancer Diagnostics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Brain Cancer Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems and Hitachi, Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Brain Cancer Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Brain Cancer Diagnostics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Brain Cancer Diagnostics Market, Segmentation by Type
    Imaging Test
    Lumbar Puncture
    Biopsy
    Molecular Testing
    Others

Global Brain Cancer Diagnostics Market, Segmentation by Application
    Hospitals
    Specialty Clinics
    Others

Companies Profiled:
    Thermo Fisher Scientific Inc.
    Siemens Healthineers AG
    GE Healthcare
    MDxHealth
    NantOmics
    Biocept, Inc.
    Koninklijke Philips N.V.
    Canon Medical Systems
    Hitachi, Ltd.
    Neusoft Medical Systems

Key Questions Answered
1. How big is the global Brain Cancer Diagnostics market?
2. What is the demand of the global Brain Cancer Diagnostics market?
3. What is the year over year growth of the global Brain Cancer Diagnostics market?
4. What is the total value of the global Brain Cancer Diagnostics market?
5. Who are the major players in the global Brain Cancer Diagnostics market?

Table of Contents

1 Supply Summary
    1.1 Brain Cancer Diagnostics Introduction
    1.2 World Brain Cancer Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Brain Cancer Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World Brain Cancer Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Brain Cancer Diagnostics Market Size (2019-2030)
        1.3.3 China Brain Cancer Diagnostics Market Size (2019-2030)
        1.3.4 Europe Brain Cancer Diagnostics Market Size (2019-2030)
        1.3.5 Japan Brain Cancer Diagnostics Market Size (2019-2030)
        1.3.6 South Korea Brain Cancer Diagnostics Market Size (2019-2030)
        1.3.7 ASEAN Brain Cancer Diagnostics Market Size (2019-2030)
        1.3.8 India Brain Cancer Diagnostics Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Brain Cancer Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Brain Cancer Diagnostics Major Market Trends

2 Demand Summary
    2.1 World Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.2 World Brain Cancer Diagnostics Consumption Value by Region
        2.2.1 World Brain Cancer Diagnostics Consumption Value by Region (2019-2024)
        2.2.2 World Brain Cancer Diagnostics Consumption Value Forecast by Region (2025-2030)
    2.3 United States Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.4 China Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.5 Europe Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.6 Japan Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.7 South Korea Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.8 ASEAN Brain Cancer Diagnostics Consumption Value (2019-2030)
    2.9 India Brain Cancer Diagnostics Consumption Value (2019-2030)

3 World Brain Cancer Diagnostics Companies Competitive Analysis
    3.1 World Brain Cancer Diagnostics Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Brain Cancer Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Brain Cancer Diagnostics in 2023
        3.2.3 Global Concentration Ratios (CR8) for Brain Cancer Diagnostics in 2023
    3.3 Brain Cancer Diagnostics Company Evaluation Quadrant
    3.4 Brain Cancer Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 Brain Cancer Diagnostics Market: Region Footprint
        3.4.2 Brain Cancer Diagnostics Market: Company Product Type Footprint
        3.4.3 Brain Cancer Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Brain Cancer Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Brain Cancer Diagnostics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Brain Cancer Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Brain Cancer Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: Brain Cancer Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Brain Cancer Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Brain Cancer Diagnostics Companies and Market Share, 2019-2024
        4.3.1 United States Based Brain Cancer Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Brain Cancer Diagnostics Revenue, (2019-2024)
    4.4 China Based Companies Brain Cancer Diagnostics Revenue and Market Share, 2019-2024
        4.4.1 China Based Brain Cancer Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Brain Cancer Diagnostics Revenue, (2019-2024)
    4.5 Rest of World Based Brain Cancer Diagnostics Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Brain Cancer Diagnostics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Brain Cancer Diagnostics Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Brain Cancer Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Imaging Test
        5.2.2 Lumbar Puncture
        5.2.3 Biopsy
        5.2.4 Molecular Testing
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Brain Cancer Diagnostics Market Size by Type (2019-2024)
        5.3.2 World Brain Cancer Diagnostics Market Size by Type (2025-2030)
        5.3.3 World Brain Cancer Diagnostics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Brain Cancer Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Specialty Clinics
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Brain Cancer Diagnostics Market Size by Application (2019-2024)
        6.3.2 World Brain Cancer Diagnostics Market Size by Application (2025-2030)
        6.3.3 World Brain Cancer Diagnostics Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Thermo Fisher Scientific Inc.
        7.1.1 Thermo Fisher Scientific Inc. Details
        7.1.2 Thermo Fisher Scientific Inc. Major Business
        7.1.3 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Product and Services
        7.1.4 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
        7.1.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    7.2 Siemens Healthineers AG
        7.2.1 Siemens Healthineers AG Details
        7.2.2 Siemens Healthineers AG Major Business
        7.2.3 Siemens Healthineers AG Brain Cancer Diagnostics Product and Services
        7.2.4 Siemens Healthineers AG Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Siemens Healthineers AG Recent Developments/Updates
        7.2.6 Siemens Healthineers AG Competitive Strengths & Weaknesses
    7.3 GE Healthcare
        7.3.1 GE Healthcare Details
        7.3.2 GE Healthcare Major Business
        7.3.3 GE Healthcare Brain Cancer Diagnostics Product and Services
        7.3.4 GE Healthcare Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 GE Healthcare Recent Developments/Updates
        7.3.6 GE Healthcare Competitive Strengths & Weaknesses
    7.4 MDxHealth
        7.4.1 MDxHealth Details
        7.4.2 MDxHealth Major Business
        7.4.3 MDxHealth Brain Cancer Diagnostics Product and Services
        7.4.4 MDxHealth Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 MDxHealth Recent Developments/Updates
        7.4.6 MDxHealth Competitive Strengths & Weaknesses
    7.5 NantOmics
        7.5.1 NantOmics Details
        7.5.2 NantOmics Major Business
        7.5.3 NantOmics Brain Cancer Diagnostics Product and Services
        7.5.4 NantOmics Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 NantOmics Recent Developments/Updates
        7.5.6 NantOmics Competitive Strengths & Weaknesses
    7.6 Biocept, Inc.
        7.6.1 Biocept, Inc. Details
        7.6.2 Biocept, Inc. Major Business
        7.6.3 Biocept, Inc. Brain Cancer Diagnostics Product and Services
        7.6.4 Biocept, Inc. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Biocept, Inc. Recent Developments/Updates
        7.6.6 Biocept, Inc. Competitive Strengths & Weaknesses
    7.7 Koninklijke Philips N.V.
        7.7.1 Koninklijke Philips N.V. Details
        7.7.2 Koninklijke Philips N.V. Major Business
        7.7.3 Koninklijke Philips N.V. Brain Cancer Diagnostics Product and Services
        7.7.4 Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Koninklijke Philips N.V. Recent Developments/Updates
        7.7.6 Koninklijke Philips N.V. Competitive Strengths & Weaknesses
    7.8 Canon Medical Systems
        7.8.1 Canon Medical Systems Details
        7.8.2 Canon Medical Systems Major Business
        7.8.3 Canon Medical Systems Brain Cancer Diagnostics Product and Services
        7.8.4 Canon Medical Systems Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Canon Medical Systems Recent Developments/Updates
        7.8.6 Canon Medical Systems Competitive Strengths & Weaknesses
    7.9 Hitachi, Ltd.
        7.9.1 Hitachi, Ltd. Details
        7.9.2 Hitachi, Ltd. Major Business
        7.9.3 Hitachi, Ltd. Brain Cancer Diagnostics Product and Services
        7.9.4 Hitachi, Ltd. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Hitachi, Ltd. Recent Developments/Updates
        7.9.6 Hitachi, Ltd. Competitive Strengths & Weaknesses
    7.10 Neusoft Medical Systems
        7.10.1 Neusoft Medical Systems Details
        7.10.2 Neusoft Medical Systems Major Business
        7.10.3 Neusoft Medical Systems Brain Cancer Diagnostics Product and Services
        7.10.4 Neusoft Medical Systems Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Neusoft Medical Systems Recent Developments/Updates
        7.10.6 Neusoft Medical Systems Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Brain Cancer Diagnostics Industry Chain
    8.2 Brain Cancer Diagnostics Upstream Analysis
    8.3 Brain Cancer Diagnostics Midstream Analysis
    8.4 Brain Cancer Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Brain Cancer Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Brain Cancer Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Brain Cancer Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Brain Cancer Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Brain Cancer Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Brain Cancer Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Brain Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Brain Cancer Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Brain Cancer Diagnostics Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Brain Cancer Diagnostics Players in 2023
    Table 12. World Brain Cancer Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Brain Cancer Diagnostics Company Evaluation Quadrant
    Table 14. Head Office of Key Brain Cancer Diagnostics Player
    Table 15. Brain Cancer Diagnostics Market: Company Product Type Footprint
    Table 16. Brain Cancer Diagnostics Market: Company Product Application Footprint
    Table 17. Brain Cancer Diagnostics Mergers & Acquisitions Activity
    Table 18. United States VS China Brain Cancer Diagnostics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Brain Cancer Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Brain Cancer Diagnostics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Brain Cancer Diagnostics Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Brain Cancer Diagnostics Revenue Market Share (2019-2024)
    Table 23. China Based Brain Cancer Diagnostics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Brain Cancer Diagnostics Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Brain Cancer Diagnostics Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Brain Cancer Diagnostics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Brain Cancer Diagnostics Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Brain Cancer Diagnostics Revenue Market Share (2019-2024)
    Table 29. World Brain Cancer Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Brain Cancer Diagnostics Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Brain Cancer Diagnostics Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Brain Cancer Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Brain Cancer Diagnostics Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Brain Cancer Diagnostics Market Size by Application (2025-2030) & (USD Million)
    Table 35. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
    Table 36. Thermo Fisher Scientific Inc. Major Business
    Table 37. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Product and Services
    Table 38. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Thermo Fisher Scientific Inc. Recent Developments/Updates
    Table 40. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    Table 41. Siemens Healthineers AG Basic Information, Area Served and Competitors
    Table 42. Siemens Healthineers AG Major Business
    Table 43. Siemens Healthineers AG Brain Cancer Diagnostics Product and Services
    Table 44. Siemens Healthineers AG Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Siemens Healthineers AG Recent Developments/Updates
    Table 46. Siemens Healthineers AG Competitive Strengths & Weaknesses
    Table 47. GE Healthcare Basic Information, Area Served and Competitors
    Table 48. GE Healthcare Major Business
    Table 49. GE Healthcare Brain Cancer Diagnostics Product and Services
    Table 50. GE Healthcare Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. GE Healthcare Recent Developments/Updates
    Table 52. GE Healthcare Competitive Strengths & Weaknesses
    Table 53. MDxHealth Basic Information, Area Served and Competitors
    Table 54. MDxHealth Major Business
    Table 55. MDxHealth Brain Cancer Diagnostics Product and Services
    Table 56. MDxHealth Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. MDxHealth Recent Developments/Updates
    Table 58. MDxHealth Competitive Strengths & Weaknesses
    Table 59. NantOmics Basic Information, Area Served and Competitors
    Table 60. NantOmics Major Business
    Table 61. NantOmics Brain Cancer Diagnostics Product and Services
    Table 62. NantOmics Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. NantOmics Recent Developments/Updates
    Table 64. NantOmics Competitive Strengths & Weaknesses
    Table 65. Biocept, Inc. Basic Information, Area Served and Competitors
    Table 66. Biocept, Inc. Major Business
    Table 67. Biocept, Inc. Brain Cancer Diagnostics Product and Services
    Table 68. Biocept, Inc. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Biocept, Inc. Recent Developments/Updates
    Table 70. Biocept, Inc. Competitive Strengths & Weaknesses
    Table 71. Koninklijke Philips N.V. Basic Information, Area Served and Competitors
    Table 72. Koninklijke Philips N.V. Major Business
    Table 73. Koninklijke Philips N.V. Brain Cancer Diagnostics Product and Services
    Table 74. Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Koninklijke Philips N.V. Recent Developments/Updates
    Table 76. Koninklijke Philips N.V. Competitive Strengths & Weaknesses
    Table 77. Canon Medical Systems Basic Information, Area Served and Competitors
    Table 78. Canon Medical Systems Major Business
    Table 79. Canon Medical Systems Brain Cancer Diagnostics Product and Services
    Table 80. Canon Medical Systems Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Canon Medical Systems Recent Developments/Updates
    Table 82. Canon Medical Systems Competitive Strengths & Weaknesses
    Table 83. Hitachi, Ltd. Basic Information, Area Served and Competitors
    Table 84. Hitachi, Ltd. Major Business
    Table 85. Hitachi, Ltd. Brain Cancer Diagnostics Product and Services
    Table 86. Hitachi, Ltd. Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Hitachi, Ltd. Recent Developments/Updates
    Table 88. Neusoft Medical Systems Basic Information, Area Served and Competitors
    Table 89. Neusoft Medical Systems Major Business
    Table 90. Neusoft Medical Systems Brain Cancer Diagnostics Product and Services
    Table 91. Neusoft Medical Systems Brain Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 92. Global Key Players of Brain Cancer Diagnostics Upstream (Raw Materials)
    Table 93. Brain Cancer Diagnostics Typical Customers
List of Figure
    Figure 1. Brain Cancer Diagnostics Picture
    Figure 2. World Brain Cancer Diagnostics Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Brain Cancer Diagnostics Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Brain Cancer Diagnostics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Brain Cancer Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Brain Cancer Diagnostics Revenue (2019-2030) & (USD Million)
    Figure 13. Brain Cancer Diagnostics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Brain Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Brain Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Brain Cancer Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Brain Cancer Diagnostics Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Brain Cancer Diagnostics Markets in 2023
    Figure 27. United States VS China: Brain Cancer Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Brain Cancer Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Brain Cancer Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Brain Cancer Diagnostics Market Size Market Share by Type in 2023
    Figure 31. Imaging Test
    Figure 32. Lumbar Puncture
    Figure 33. Biopsy
    Figure 34. Molecular Testing
    Figure 35. Others
    Figure 36. World Brain Cancer Diagnostics Market Size Market Share by Type (2019-2030)
    Figure 37. World Brain Cancer Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Brain Cancer Diagnostics Market Size Market Share by Application in 2023
    Figure 39. Hospitals
    Figure 40. Specialty Clinics
    Figure 41. Others
    Figure 42. Brain Cancer Diagnostics Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Thermo Fisher Scientific Inc.
Siemens Healthineers AG
GE Healthcare
MDxHealth
NantOmics
Biocept, Inc.
Koninklijke Philips N.V.
Canon Medical Systems
Hitachi, Ltd.
Neusoft Medical Systems